May 28, 2016
Recommended Topic Related To:

Lufyllin

"The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a hi"...

A A A

Lufyllin




PATIENT INFORMATION

No Information Provided.

See WARNINGS and PRECAUTIONS sections

Last reviewed on RxList: 1/20/2005
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.